News from Tamar, Teva, Fox and Adama, Tel Aviv shares dip.
The central bank chief, however, notes that she has record foreign currency reserves with which to intervene in the market.
IDB group's new controllers clash over both style and substance.
Announcement comes two days after Teva Pharmaceutical Industries sold back its stake in the drug firm and its flagship diabetes treatment.
Argentinean investor Eduardo Elsztain and Moti Ben-Moshe, his Israeli partner in IDB, just can’t get on with each other, but the bondholders look safe.
Executives from Warren Buffet’s Berkshire Hathaway meet with Shlomo Group, while some economists predict cut in base interest rates for March.
Supporters are drawn to its decentralized platform. Detractors call it a bubble prone to be exploited by criminals.
Supporters are drawn to its decentralized platform. Detractors call it a bubble.
The 0.6% fall led by big 7.7% decline in cost of clothing and shoes, although fresh vegetable prices rose 3.8%.
Relisting would see IDB back on TASE after four-year absence, with new owners Eduardo Elsztain and Moti Ben-Moshe set to turn IDB Holding Corp. into shell company.